[-] Show simple item record

dc.contributor.authorLoomis, Lucy W.
dc.date.issued2001-10eng
dc.description.abstractTight control of hypertension treatment is key in preventing the vascular complications of diabetes. ACE inhibitors appear to have a protective effect that is independent of their antihypertensive effect. Unless there is a contraindication, all patients with diabetes who have hypertension should be treated with ACE inhibitors. Patients with diabetes who have microalbuminuria should be treated with ACE inhibitors, even if normotensive, as should those with overt nephropathy. (Grade of recommendation: A, based on randomized controlled trials.)en
dc.identifier.urihttp://hdl.handle.net/10355/2823
dc.publisherFamily Physicians Inquiries Networken
dc.relation.ispartofClinical Inquiries, 2001 (MU)en
dc.relation.ispartofcommunityUniversity of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Network
dc.subjectmicroalbuminuriaen
dc.subjectretinopathyen
dc.subjectnephropathyen
dc.subject.lcshHypertensionen
dc.subject.lcshAngiotensin-Converting Enzyme Inhibitorsen
dc.subject.lcshDiabetic nephropathiesen
dc.titleWhat are the indications for treatment with angiotensin-converting enzyme (ACE) inhibitors in patients with diabetes?en
dc.typeArticleen


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record